Peficitinib Market In Global
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy ... Read More
Indoprofen(CAS 31842-01-0) is a non-steroidal drug, which can show a range of pharmacological properties such as analgesic and anti-inflammatory activities.
This report contains market size and forecasts of Indoprofen in global, including the following market information:
Global Indoprofen Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Indoprofen Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Indoprofen companies in 2021 (%)
The global Indoprofen market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Indoprofen include TargetMol, Selleck Chemicals, LGC, MyBiosource, AbMole, Santa Cruz Biotechnology, Toronto Research Chemicals, Merck and Biorbyt, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Indoprofen manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Indoprofen Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoprofen Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Indoprofen Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoprofen Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Indoprofen Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Indoprofen Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Indoprofen revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Indoprofen revenues share in global market, 2021 (%)
Key companies Indoprofen sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Indoprofen sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
TargetMol
Selleck Chemicals
LGC
MyBiosource
AbMole
Santa Cruz Biotechnology
Toronto Research Chemicals
Merck
Biorbyt
CSNpharm
Taiclone
Aladdin
Peficitinib(CAS 944118-01-8) is a novel potent JAK inhibitor, which demonstrated potent efficacy ... Read More
Baricitinib (CAS 1187594-09-7) is an orally bioavailable inhibitor of Janus kinases 1 and 2, with ... Read More
Valrubicin (CAS 56124-62-0) is a semisynthetic derivative of the antineoplastic anthracycline ant ... Read More
Preladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor. ... Read More